THE IMPACT OF TESTOSTERONE-REPLACEMENT THERAPY (TRT) ON BENIGN PROSTATIC HYPERPLASIA (BPH) INCIDENCE AND NEED FOR INTERVENTIONS IN HYPOGONADAL MEN

被引：0
|
作者：
Fendereski, K. [1 ]
Horns, J. [1 ]
Hotaling, J. [1 ]
机构：
[1] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2023年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
065
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE BUDGET IMPACT OF TREATMENT PATHWAY REDESIGN IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA (BPH)
    Patel, S.
    Garnham, A.
    Nazir, J.
    VALUE IN HEALTH, 2015, 18 (03) : A186 - A187
  • [22] Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality
    Van Rompay, Maria I.
    Nickel, J. Curtis
    Ranganathan, Gayatri
    Kantoff, Philip W.
    Solomon, Keith R.
    Lund, Jennifer L.
    McKinlay, John B.
    BJU INTERNATIONAL, 2019, 123 (03) : 511 - 518
  • [23] Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Berges, Richard
    Hoefner, Klaus
    Gedamke, Michael
    Oelke, Matthias
    WORLD JOURNAL OF UROLOGY, 2014, 32 (05) : 1163 - 1170
  • [24] Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Richard Berges
    Klaus Höfner
    Michael Gedamke
    Matthias Oelke
    World Journal of Urology, 2014, 32 : 1163 - 1170
  • [25] Long-term therapy with the dual 5α-reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia (BPH)
    Fenter, T
    Tully, S
    Debruyne, F
    JOURNAL OF UROLOGY, 2004, 171 (04): : 358 - 358
  • [26] Impact of therapy used in clinical practice on lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) disease progression
    Berges, R
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 19 - 24
  • [27] Re: Impact of 5α-Reductase Inhibitor and α-Blocker Therapy for Benign Prostatic Hyperplasia on Prostate Cancer Incidence and Mortality
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2020, 203 (05): : 856 - 857
  • [28] Urinary toxicity in men treated with stereotactic body radiation therapy (SBRT) for localized prostate cancer following procedures for benign prostatic hyperplasia (BPH).
    Kataria, Shaan
    Tsou, Harry
    Datta, Subhradeep
    Gurka, Marie Kate
    Lei, Siyuan
    Ayoob, Marilyn
    Danner, Malika
    Yung, Thomas M.
    Collins, Brian Timothy
    Krishnan, Pranay
    Suy, Simeng
    Lynch, John J.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] EFFECTS OF INTERRUPTING AND RESUMING LONG-TERM TESTOSTERONE REPLACEMENT THERAPY (TRT) WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) ON ERECTILE DYSFUNCTION (ED) AND ANTHROPOMETRIC PARAMETERS IN HYPOGONADAL MEN IN AN OBSERVATIONAL REGISTRY STUDY
    Saad, F.
    Yassin, A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 402 - 402
  • [30] The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and Its Potential Impact on Medical Therapy
    Ficarra, Vincenzo
    Rossanese, Marta
    Zazzara, Michele
    Giannarini, Gianluca
    Abbinante, Maria
    Bartoletti, Riccardo
    Mirone, Vincenzo
    Scaglione, Francesco
    CURRENT UROLOGY REPORTS, 2014, 15 (12)
12345